Enabling precision immunology
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $50M
Investors 4
| Date | Name | Website |
| 04.06.2021 | Alta Partn... | altapartne... |
| 26.03.2022 | ARCH Ventu... | archventur... |
| - | DC Investm... | dcinvestme... |
| - | Xfund | xfund.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.06.2021 | Series A | $50M | - |
Mentions in press and media 10
| Date | Title | Description |
| 23.06.2021 | ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics | ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that it has raised $50 million in Series A financing. T... |
| 23.06.2021 | ImmuneID Inks $50M Series A | CAMBRIDGE, MA, ImmuneID, a precision immunology company, has raised $50 million in Series A financing led by Alta Partners. >> Click here for more funding data on ImmuneID >> To export ImmuneID funding data to PDF and Excel,... |
| 23.06.2021 | Former Department of Transportation Secretary, Elaine Chao, returns to the private sector | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. After a tumultuous 2020 election that culminated in an insurrection at the U.S. Capitol, many won... |
| 23.06.2021 | Former Department of Transportation Secretary, Elaine Chao, returns to the private sector | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why a company’s ethics are as important as its products From Moodys After a tumultuo... |
| 17.02.2021 | ImmuneID Launches with $17M Financing to Profile and Modulate Immune Response at Unprecedented Scale and Resolution | Lea Hachigian Like this: Like Loading... Related |
| 17.02.2021 | ImmuneID Raises $17M in Funding | Lea Hachigian, Ph.D., founding CEO ImmuneID, Inc., a Cambridge, Mass.-based precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, raised $17M i... |
| 17.02.2021 | Longwood Fund-backed precision immunology startup launches with $17M | One year ago, geneticist Stephen Elledge was hard at work trying to figure out how to use his genetic sequencing platform to target SARS-CoV-2. A decorated professor of genetics at Harvard Medical School and Brigham and Women's Hospital, El... |
| 17.02.2021 | ImmuneID Launches with $17M Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, announced a $17M financing led by fo... |
| 17.02.2021 | In-Q-Tel Joins $17 Million for ImmuneID | CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, announced a $17M financing led by fo... |
| - | Manage your consent preferences Longwood Fund-backed precision immunology startup launches with $17M | - |